Segment disclosures

Company overview

SpringWorks Therapeutics, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 5 retained observations 5 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Developing And Commercializing Life Changing Medicines

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=swtx:DevelopingAndCommercializingLifeChangingMedicinesMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-3149087000 USD20250509Open filing evidence
2024-01-01 – 2024-12-31191589000 USD20250220Open filing evidence
2024-01-01 – 2024-03-3121006000 USD20250509Open filing evidence
2023-01-01 – 2023-12-315447000 USD20250220Open filing evidence
2022-01-01 – 2022-12-310 USD20250220Open filing evidence